Stryker to Acquire Sterilization Specialist TSO3

TSO3, a Canadian company specializing in sterilization technology for medical devices, has agreed to be acquired by Stryker for CAD $68.4MM (USD $51.7MM). The transaction is expected to close in 4Q19.

TSO3 markets and licenses sterilization processes related to supplies and accessories for heat-sensitive medical devices.

The STERIZONE® VP4 Sterilizer, which is cleared in the U.S., Canada and Europe, is reportedly the most cost-effective low-temperature sterilizer on the market today per instrument sterilized, compared to hydrogen peroxide low-temperature sterilizers. It can sterilize orthopedic tools and batteries in the same load, saving time and costs.

The company provides a compatibility matrix to match devices to their low-temperature sterilization processes.

TSO3 also offers testing services to medical device manufacturers to validate and test the compatibility of devices in TSO3’s STERIZONE system.

For Stryker, the move comes at a time when companies are searching for innovative ways to make instruments more sustainable, cost-effective and efficient to manage. The EcoSmart program from CrossRoads Extremity Systems is just one example of ways that OEMs seek to solve pain points around re-sterilization for their customers. With the acquisition of TSO3, Stryker may see the opportunity for a similar program.

 

JAV

Julie A. Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

RELATED ARTICLES



CONTACT BONEZONE

 

CONTACT BONEZONE